HYDROARQ Trademark

Trademark Overview

On Tuesday, July 13, 2021, a trademark application was filed for HYDROARQ with the United States Patent and Trademark Office. The USPTO has given the HYDROARQ trademark a serial number of 90825921. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, August 20, 2024. This trademark is owned by Arcutis Biotherapeutics, Inc.. The HYDROARQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical creams that facilitate the topical administration of pharmaceuticals for the treatment of dermatological conditions, diseases and disorders
hydroarq

General Information

Serial Number90825921
Word MarkHYDROARQ
Filing DateTuesday, July 13, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, August 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 28, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical creams that facilitate the topical administration of pharmaceuticals for the treatment of dermatological conditions, diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArcutis Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWestlake Village, CA 91361
Party NameArcutis Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestlake Village, CA 91361

Trademark Events

Event DateEvent Description
Friday, July 16, 2021NEW APPLICATION ENTERED
Monday, November 22, 2021ASSIGNED TO EXAMINER
Friday, September 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 28, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 18, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 18, 2022SOU EXTENSION 1 FILED
Thursday, August 18, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 21, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 21, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 21, 2023SOU EXTENSION 3 FILED
Monday, August 21, 2023SOU EXTENSION 3 GRANTED
Wednesday, August 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 21, 2023SOU EXTENSION 2 FILED
Tuesday, February 21, 2023SOU EXTENSION 2 GRANTED
Thursday, February 15, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 15, 2024SOU EXTENSION 4 FILED
Thursday, February 15, 2024SOU EXTENSION 4 GRANTED
Tuesday, August 20, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU EXTENSION 5 FILED
Wednesday, August 21, 2024SOU EXTENSION 5 GRANTED
Friday, February 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

hydroarq pharmaceutical treatment dermatological conditions disorders diseases pharmaceuticals administration preparations namely